MedCity News March 24, 2024
Frank Vinluan

Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based pharma companies. The survey was conducted in late 2023 and results were reported this month.

The commercial teams of pharmaceutical companies are looking for more data analytics and business insights and they’re willing to spend more money to do it. Those are some of the findings of a recent survey of pharma industry executives at U.S.-based companies.

The survey was conducted by independent survey company Global Surveyez, but it was commissioned by Verix, a Santa Clara, California-based company that provides an AI-based technology platform that supports life sciences commercial operations. In other words, it has a financial interest in the topics covered...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Analytics, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
Related Articles:
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices

Share This Article